Skip to main
MDNA
MDNA logo

MDNA Earnings Dates & Reports

MDNA Most Recent Earnings

Report Date
Period EndingQ2 2024
Est. EPS-$0.05
Actual EPS-$0.04
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MDNA Earnings per Share (EPS) History

Signup for full access
Browse free

MDNA Latest Earnings

The value each MDNA share was expected to gain vs. the value each share gained.

MDNA reported its most recent earnings on for Q2 2024, posting earnings per share (EPS) of -$0.04. This exceeded analysts' expectations of -$0.05 by 20.00%, marking a Beat.

For comparison, Medicenna Therapeutics Corp reported EPS of -$0.01 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

MDNA Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2024
-$0.05-$0.04-20.00%
DeckReportListen
Q1 2024
-$0.05-$0.03-40.00%
DeckReportListen
Q4 2023
-$0.07-$0.04-42.86%
DeckReportListen
Q3 2023
-$0.07-$0.02-78.57%
DeckReportListen
Q2 2023
-$0.01
DeckReportListen
View all

MDNA Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Medicenna Therapeutics Corp’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

MDNA Earnings FAQs

MDNA last reported earnings on Nov 13, 2023 for Q2 2024, posting an EPS of -$0.04, which Beat the estimate of -$0.05 by 20.00%.

For Q2 2024, MDNA reported an EPS of -$0.04, exceeding analysts' estimate of -$0.05 by 20.00%.

For Q2 2024, MDNA Beat expectations with an actual EPS of -$0.04 vs. an estimated EPS of -$0.05.

Following the last earnings report on Nov 13, 2023, MDNA's stock price moved — from — to —.

The next MDNA earnings call is scheduled for Nov. 13, 2023, where executives will discuss financial results and outlook.

Medicenna Therapeutics Corp (MDNA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.